1 1

Fluvac Innovator EHV-4/1

Fluvac Innovator EHV-4/1

$27.00
$27.00
Sale Sold out
Dosage: Inject 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose in unvaccinated or naïve horses. A 1 mL annual revaccination in previously vaccinated horses is recommended.
Size
View full details

Fluvac Innovator® EHV-4/1

Available in Single Dose Syringe & 10 Dose Bottle

FLUVAC INNOVATOR vaccines deliver demonstrated protection against circulating contemporary equine influenza viruses (EIV) and aid in the prevention of equine influenza due to type A2 viruses, and equine rhinopneumonitis due to equine herpes virus (EHV) types 1 and 4.

  • Key Benefits

    Product Highlights

    • FLUVAC INNOVATOR is the only vaccine with EIV strain KY ’97 that has demonstrated protection against heterologous challenge with EIV strain OH ’032
    • FLUVAC INNOVATOR is the only EIV vaccine shown to help protect against clinical signs for seven months against a heterologous, dual-strain challenge3
    • In addition to EIV, FLUVAC INNOVATOR vaccines also contain both EHV-1 and EHV-4 to help protect against rhinopneumonitis
    • Only INNOVATOR vaccines are adjuvanted with MetaStim for improved immune response4

     

  • Dosing and Administration

    FLUVAC INNOVATOR

    Inject 1 mL dose intramuscularly using aseptic technique.

    Administer a second 1 mL dose 3 to 4 weeks after the first dose in unvaccinated or naïve horses.

    A 1 mL annual revaccination in previously vaccinated horses is recommended.

    Always read and follow label indications

    Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make exposure likely.